Recombinant Viral Vector Vaccines for the Veterinary Use

Journal of Veterinary Medical Science

Volumn 59, Issue 5, 1997, Pages 311-322

  Yokoyama, Naoaki ^a   Maeda, Ken ^b   Mikami, Takeshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Recombinant polyvalent vaccine; Recombinant vaccine; Viral vector

Indexed keywords

VACCINIA; VACCINIA VIRUS;

DNA VACCINE; LIVE VACCINE; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; GENE VECTOR; GENETIC ENGINEERING; HERPES VIRUS INFECTION; IMMUNOLOGY; REVIEW; VIRUS INFECTION;

ANIMALS; GENETIC ENGINEERING; GENETIC VECTORS; HERPESVIRIDAE INFECTIONS; VACCINES, ATTENUATED; VACCINES, DNA; VIRAL VACCINES; VIRUS DISEASES;

EID: 0031132390     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.59.311     Document Type: Review

References (135)

1. Adam, M., Lepottier, M. F., and Eloit, M. 1994. Vaccination of pigs with replication-defective adenovirus vectored vaccines: the example of pseudorabies. Ver. Microbiol. 42: 205-215.
2. Alkhatib, G. and Briedis, D. J. 1988. High-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system. J. Virol. 62: 2718-2727.
3. Babic, N., Mettenleiter, T. C., Ugolini, G., Flamand, A., and Coulon, P. 1994. Propagation of pseudorabies virus in the nervous system of the mouse after intranasal inoculation. Virology 204: 616-625.
4. Baxy, D. and Paoletti, E. 1992. Potential use of non-replicating vectors as recombinant vaccines. Vaccine 10: 8-9.
5. Bayliss, C. D., Peters, R. W., Cook, J. K. A., Reece, R. L. Howes, K., Binns, M. M., and Boursnell, M. E. G. 1991. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch. Virol. 120: 193-205.
6. Beard, C. W., Schnitzlein, W. M., and Tripathy, D. N. 1991. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Dis. 35: 356-359.
7. Bertagnoli, S., Gelfi, J., Petit, F., Vautherot, J. F., Rasschaert, D., Laurent, S., Le Gall, G., Boilletot, E., Chantal, J., and Boucraut-Baralon, C. 1996. Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus. Vaccine 14: 506-510.
8. Blancou, J., Kieny, M. P., Lathe, R., Lecocq, J. P., Pastoret, P. P., Soulebot, J. P., and Desmettre, P. 1986. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature (Land ) 322: 373-375.
9. Boursnell, M. E. G., Green, P. F., Campbell, J. I. A., Deuter, A., Peters, R. W., Tomley, F. M., Samson, A. C. R., Chambers, P., Emmerson, P. T., and Binns, M. M. 1990. Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant. J. Gen. Virol. 71: 621-628.
10. Breker-Klassen, M. M., Yoo, D., Mittal, S. K., Sorden, S. D., Haines, D. M., and Babiuk, L. A. 1995. Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection. J. Virol. 69: 4308-4315.
11. Brochier, B., Kieny, M. P., Costy, F., Coppens, P., Bauduin, B., Lecocq, J. P., Languet, B., Chappuis, G., Desmettre, P., Afiademanyo, K., Libois, R., and Pastoret, P.-P. 1991. Largescale eradication of rabies using reocombinant vacciniarabies vaccine. Nature (Lond.) 354: 520-522.
12. Brockmeier, S. L., Lager, K. M., Tartaglia, J., Riviere, M., Paoletti, E., and Mengeling, W. L. 1993. Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses. Vet. Microbiol. 38: 41-58.
13. Calvert, J. G., Nazerian, K., Witter, R. L., and Yanagida, N. 1993. Fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus induce neutralizing antibodies and reduce viremia in chickens. J. Virol. 67: 3069-3076.
14. Cameron, J. M., McDougall, I., Marsden, H. S., Preston, V. G., Ryan, D. M., and Subak-Sharpe, J. H. 1988. Ribonucleotide reductase encoded by herpes simplex virus is a determinant of pathogenicity of the virus in mice and a valid antiviral target. J. Gen. Virol. 69: 2607-2612.
15. Caravokyri, C., Pringle, C. R., and Leppard, K. N. 1993. Human adenovirus type 5 recombinants expressing simian immunodeficiency virus macaque strain gag antigens. J. Gen. Viral. 74: 2819-2824.
16. Chengalvala, M. V., Bhat, B. M., Bhat, R., Lubeck, M. D., Mizutani, S., Davis, A. R., and Hung, P. P. 1994. Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs. J. Gen. Virol. 75: 125-131.
17. Cole, G. E., Stacy-Phipps, S., and Nunberg, J. H. 1990. Recombinant feline herpesviruses expressing feline leukemia virus envelope and gag proteins. J. Virol. 64: 4930-4938.
18. Cox, W. I., Tartaglia, J., and Paoletti, E. 1992. Poxvirus recombinants as live vaccines. pp. 123-162. In: Recombinant Poxviruses (Binns, M. M. and Smith, G. L. eds.), CRC Press, Boca Raton.
19. Crandell, R. A., Fabricant, C. G., and Nelson-Rees, W. A. 1973. Development, characterization, and viral susceptibility of a feline (Felis catrus) renal cell line (CRFK). In Vitro 9: 176-185.
20. Darteil, R., Bublot, M., Laplace, E., Bouquet, J.-F., Audonnet, J.-C., and Riviere, M. 1995. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 211: 481-490.
21. Efstathiou, S., Kemp, S., Darby, G., and Minson, A. C. 1989. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J. Gen. Virol. 70: 869-879.
22. Elott, M., Gilardi-Hebenstreit, P., Toma, B., and Perricaudet, M. 1990. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. J. Gen. Virol. 71: 2425-2431.
23. Enquist, L. W. 1994. Infection of the mammalian nervous system by pseudorabies virus (PRV). Semin. Virol. 5: 221-231.
24. Esposito, J. J., Knight, J. C., Shaddock, J. H., Novembre, F. J., and Baer, G. M. 1988. Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein. Virology 165: 313-316.
25. Field, H. J. and Wildy, P. 1978. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus. J. Hyg. 81: 267-277.
26. Flores, E. F., Osorio, F. A., Zanella, E. L., Kit, S., and Kit, M. 1993. Efficacy of a deletion mutant bovine herpesvirus-I (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals. J. Vet. Diagn. Invest. 5: 534-540.
27. Flowers, C. C. and O'Callaghan, D. J. 1992. The equine herpesvirus type I (EHV-I) homolog of herpes simplex virus type 1 US9 and the nature of a major deletion within the unique short segment of the EHV-I KyA strain genome. Virology 190: 307-315.
28. Fooks, A. R., Schadeck, E., Lieben, U. G., Dowsett, A. B., Rima, B. K., Steward, M., Stephenson, J. R., and Wilkinson, G. W. G. 1995. High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: Induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 210: 456-465.
29. Fries, L. F., Tartaglia, J., Taylor, J., Kauffman, E. K., Meignier, B., Paoletti, E., and Plotkin, S. 1996. Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: An alternative poxvirus vector system. Vaccine 14: 428-434.
30. Gaskell, R. M. 1989. Vaccination of the young kitten. J. Small Anim. Pract. 30: 618-624.
31. Gerard, R. D. and Meidell, R. S. 1993. Adenovirus-mediated gene transfer. Trends. Cardiovasc. Med. 3: 171-177.
32. Giavedoni, L., Jones, L., Mebus, C., and Yilma, T. 1991. A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions. Proc. Nail. Acad. Sci. U.S.A. 88: 8011-8015.
33. Graham, F. L., Smiley, J., Russel, W. C., and Nairn, R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36: 59-72.
34. Grunhaus, A. and Horwitz, M. S. 1992. Adenoviruses as cloning vectors. Semin. Virol. 3: 237-252.
35. Heine, H.-G. and Boyle, D. B. 1993. Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. Arch. Virol 131: 277-292.
36. NS glycoprotein induces neutralizing antibodies and protects against experimental infection. J. Gen. Virol. 77: 631-640.
37. Hill, T. G. 1985. Herpes simplex viruses latency. pp. 175-225. In: The Herpesviruses (Roizman, B. ed.), Plenum Press, New York and London.
38. Hooft van Iddekinge, B. J. L., De Wild, N., Wensvoort, G., Kimman, T. G., Gielkens, A. L. J., and Moormann, R. J. M. 1996. Comparison of the protective efficacy of recombinant pseudorabies viruses against pseudorabies and classical swine fever in pigs: Influence of different promoters on gene expression and on protection. Vaccine 14: 6-12.
39. Hsu, K.-H., Lubeck, M. D., Bhat, B. M., Bhat, R. A., Kostek, B., Selling, B. H., Mizutani, S., Davis, A. R., and Hung, P. P. 1994. Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model. Vaccine 12: 607-612.
40. Hu, S.-L., Abrams.K., Barber, G. N., Moran, P., Zarling, J. M., Langlois, A. L., Kuller, L , Morton, W. R., and Benveniste, R. E. 1992. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255: 456-459.
41. Hu, L., Esposito, J. J., and Scott, F. W. 1996. Raccoon poxvirus feline panleukopeia virus VP2 recombinant protects cats against FPV challenge. Virology 218: 248-252.
42. Jacobs, L. 1994. Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae. [Review]. Arch. Virol. 137: 209-228.
43. Johnson, D. C., Ghosh-Choudhury, G., Smiley, J. R., Fallis, L., and Graham, F. L. 1988. Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 164: 1-14.
44. Kawaguchi, Y., Maeda, K., Miyazawa, T., Ono, M., Kai, C., and Mikami, T. 1994. Nucleotide sequence and characterization of the feline herpesvirus type 1 immediate early gene. Virology 204: 430-435.
45. Kawaguchi, Y., Maeda, K., Ono, M., Yokoyama, N., Tsubota, K., Fujita, K., Tohya, Y., Kai, C., and Mikami, T. 1996. Characterization of the feline herpesvirus type 1 immediate early gene expression. J. Vet. Med. Sci. 58: 715-721.
46. Kawaguchi, Y., Maeda, K., Yokoyama, N., Fujita, K., Ono, M., Tohya, Y., and Mikami, T. 1997. Expression of the feline herpesvirus type 1 ICP4 gene is controlled by two alternative promoters. Arch. Virol. 142: 239-253.
47. Kimman, T. G., De Wind, N., Oei-Lei, N., Pol, J. M. A., Berns, A. J. M., and Gielkens, A. L. J. 1992. Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity. J. Gen. Virol. 73: 243-251.
48. Kimman, T. G., De Wind, N., De Bruin, T., De Visser, Y., and Voermans, J. 1994. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity. Virology 205: 511-518.
49. Kit, S.,Kit, M., and Pirtle, E. C. 1985. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus. Am. J. Vet. Res. 46. 1359-1367.
50. Kit, S., Qavi, H., Gaines, J. D., Billingsley, P., and McConnell, S. 1985. Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves. Arch. Virol. 86: 63-83.
51. Kit, S., Kit, M., and McConnell, S. 1986. Intramuscular and intravaginal vaccination of pregnant cows with thymidine kinase-negative, temperature-resistant infectious bovine rhinotracheitis virus (bovine herpesvirus 1). Vaccine 4: 55-61.
52. Kit, M., Kit, S., Little, S. P., Di Marchi, R. D., and Gale, C. 1991. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes. Vaccine 9: 564-572.
53. Kit, S., Kit, M., Di Marchi, R. D., Little, S. P., and Gale, C. 1991. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles. Arch. Virol. 120: 1-17.
54. Kit, M. and Kit, S. 1991. Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs. Vet. Microbiol. 28: 141-155.
55. Kit, S., Otsuka, H., and Kit, M. 1992. Expression of porcine pseudorabies virus genes by a bovine herpesvirus-1 (infectious bovine rhinotracheitis virus) vector. Arch. Virol. 124: 1-20.
56. Kritas, S. K., Pensaert, M. B., and Mettenleiter, T. C. 1994. Role of envelope glycoproteins gI, gp63 and gIII in the invasion and spread of Aujeszky's disease virus in the olfactory nervous pathway of the pig. J. Gen. Virol. 75: 2319-2327.
57. Kruger, J. M., Sussman, M. D., and Maes, R. K. 1996. Glycoproteins gI and gE of feline herpesvirus-1 are virulence genes: Safety and efficacy of a gI-gE: deletion mutant in the natural host. Virology 220: 299-308.
58. Letellier, C., Burny, A., and Meulemans, G. 1991. Construction of a pigeonpox virus recombinant: Expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge. Arch. Virol. 118: 43-56.
59. Lodmell, D. L., Summer, J. W., Esposito, J. J., Bellini, W. J., and Ewalt, L. C. 1991. Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection. J. Virol. 65: 3400-3405.
60. Lubeck, M. D., Natuk, R. J., Chengalvala, M., Chanda, P. K., Murthy, K. K., Murthy, S., Mizutani, S., Lee, S.-G., Wada, M. S., Bhat, B. M., Bhat, R., Dheer, S. K., Eichberg, J. W., Davis, A. R., and Hung, P. P. 1994. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res. Hum. Retroviruses 10: 1443-1449.
61. Maeda, K., Horimoto, T., Norimine, J., Kawaguchi, Y., Tomonaga, K., Niikura, M., Kai, C., Takahashi, E., and Mikami, T. 1992. Identification and nucleotide sequence of a gene in feline herpesvirus type 1 homologous to the herpes simplex virus gene encoding the glycoprotein B. Arch. Virol. 127: 387-397.
62. Maeda,K., Kawaguchi, Y., Kamiya, N., Ono, M., Tohya, Y., Kai, C., and Mikami, T. 1993. Identification and nucleotide sequence of a gene in feline herpesvirus type 1 homologous to the herpes simplex virus gene encoding the glycoprotein H. Arch. Virol. 132: 183-191.
63. Maeda,K., Kawaguchi, Y., Ono, M., Inoshima, Y., Miyazawa, T., Tohya, Y., Kai, C., and Mikami, T. 1994. A gD homologous gene of feline herpesvirus type 1 encodes a hemagglutinin (gp60). Virology 202: 1034-1038.
64. Maeda, K., Kawaguchi, Y., Ono, M., Tajima, T., and Mikami, T. 1995. Restriction endonuclease analysis of field isolates of feline herpesvirus type 1 and identification of the heterogeneous regions. J. Clin. Microbiol. 33: 217-221.
65. Maeda, K., Kawaguchi, Y., Ono, M., Tajima, T., and Mikami, T. 1995. Comparisons among feline herpesvirus type 1 isolates by immunoblot analysis. J. Vet. Med. Sci. 57. 147-150.
66. Maeda,K., Hirasawa, K., Kawaguchi, Y., Ono, M., Mori, T., Gemma, T., Yokoyama, N., DOI, K., and Mikami, T. 1995. Expression and identification of the feline herpesvirus type 1 glycoprotein B (gp 143/108). Virus Res. 39: 55-61.
67. Maeda, K., Ono, M., Kawaguchi, Y., Okazaki, M., Yokoyama, N., Tohya, Y., and Mikami, T. 1997. Adhesion of insect cells expressing the feline herpesvirus type 1 hemagglutinin (gD) to feline cell lines. J. Vet. Med. Sci. 59: 217-219.
68. Maeda, K., Yokoyama, N., Fujita, K., and Mikami, T. 1996. Identification and characterization of the feline herpesvirus type 1 glycoprotein C gene. Virus Genes. (in press).
69. Mahnel, H. 1989. Swinepox, pp. 5-15. in: Virus Infections of Porcines (Pensaert, ed.), Elsevier Science, Amsterdam.
70. Mijnes, J. D. F., Van der Horst, L. M., Van Anken, E., Horzinek, M. C., Rottier, P. J. M., and De Groot, R. J. 1996. Biosynthesis of glycoproteins E and I of feline herpesvirus: gE-gI interaction is required for intracellular transport. J. Virol. 70: 5466-5475.
71. Mittal, S. K., Papp, Z., Tikoo, S. K., Baca-Estrada, M. E., Yoo, D., Benko, M., and Babiuk, L. A. 1996. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD. Virology 222: 299-309.
72. Moormann, R. J. M., De Rover, T., Briaire, J., Peeters, B. P. H., Gielkens, A. L. J., and Van Oirschot, J. T. 1990. Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. J. Gen.Virol. 71: 1591-1595.
73. Morgan, R. W., Gelb, J. J., Schreurs, C. S., Lütticken, D., Rosenberger, J. K., and Sondermeijer, P. J. A. 1992. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Dis. 36: 858-870.
74. Morgan, R. W., Gelb, J. J., Pope, C. R., and Sondermeijer, P. J. A. 1993. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: Onset of protection and effect of maternal antibodies. Avion Dis. 37: 1032-1040.
75. Worin, J. E., Lubeck, M. D., Barton, J. E., Conley, A. J., Davis, A. R., and Hung, P. P. 1987. Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proc. Natl. Acad. Sci. U.S.A. 84: 4626-4630.
76. Moss, B., Smith, G. L., Germ, J. L., and Purcell, R. H. 1984. Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (Lond.) 311: 67-69.
77. Moss, B. 1993. Poxvirus vectors: cytoplasmic expression of transferred genes. Curr. Opin. Genet. Dev. 3: 86-90.
78. Mulder, W. A. M., Priem, J., Glazenburg, K. L., Wagenaar, F., Gruys, E., Gielkens, A. L. J., Pol, J. M. A., and Kimman, T. G. 1994. Virulence and pathogenesis of non-virulent and virulent strains of pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus. J. Gen. Virol. 75: 117-124.
79. Mulder, W. A. M., Jacobs, L., Priem, J., Kok, G. L., Wagenaar, F., Kimman, T. G., and Pol, J. M. A 1994. Glycoprotein gE-negative pseudorabies virus has a reduced capability to infect second- and third-order neurons of the olfactory and trigeminal routes in the porcine central nervous system. J. Gen. Virol. 75: 3095-3106.
80. Murphy, B. R. and Chanock, R. M. 1985. Immunization against viruses. pp. 349-370. In: Virology (Fields, B. N. ed.), Raven, New York.
81. Nazerian, K., Lee, L. F., Yanagida, N., and Ogawa, R. 1992. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus J. Virol. 66: 1409-1413.
82. Nazerian, K. and Yanagida. N. 1995. A recombinant fowlpox virus expressing the envelope antigen of subgroup A avian leukosis/sarcoma virus. Avian Dis. 39: 514-520.
83. Nunberg, J. H., Wright, D. K., Cole, G. E., Petrovskis, E. A., Post, L. E., Compton, T., and Gilbert, J. H. 1989. Identification of the thymidine kinase gene of feline herpesvirus: Use of degenerate oligonucleotides in the polymerase chain reaction to isolate herpesvirus gene homologs. J. Virol. 63: 3240-3249.
84. Ogawa, R., Yanagida, N., Saeki, S., Saito, S., Ohkawa, S., Gotoh, H., Kodama, K., Kamogawa, K., Sawaguchi, K., and Iritani, Y. 1990. Recombinant fowlpox virus inducing protective immunity against Newcastle disease and fowlpox virus. Vaccine 8: 486-490.
85. Okamura, H., Sakaguchi, M., Honda, T., Taneno, A., Matsuo, K., and Yamada, S. 1994. Construction of recombinant infectious laryngotracheitis virus expressing the lacZ gene of E. coli with thymidine kinase gene. J. Vet. Med. Sci. 56: 799-801.
86. Okazaki, W., Purchase, H. G.,and Burmester, B. R. 1970. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 14: 413-429.
87. Peeters, B., Bouma, A., De Bruin, T., Moormann, R., Gielkens, A., and Kimman, T. 1994. Non-transmissible pseudorabies virus gp50 mutants: A new generation of safe live vaccines. Vaccine 12: 375-380.
88. Petrovskis, E. A., Timmins, J. G., Gierman, T. M., and Post, L. E. 1986. Deletions in vaccine strains of pseudorabies virus and their effect on synthesis of glycoprotein gp63. J. Virol. 60: 1166-1169.
89. Prevec, L., Schneider, M., Rosenthal, K. L., Belbeck, L. W., Derbyshire, J. B., and Graham, F. L. 1989. Use of human adenovirus-based vectors for antigen expression in animals. J. Gen. Virol. 70: 429-434.
90. Prevec, L., Campbell, J. B., Christie, B. S., Belbeck, L., and Graham, F. L. 1990. A recombinant human adenovirus vaccine against rabies. J. Infect. Dis. 161: 27-30.
91. Pyles, R. B., Sawtell, N. M., and Thompso, R. L. 1992. Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency. J. Virol. 66: 6706-6713.
92. Ragot, T., Finerty, S., Watkins, P. E., Perricaudet, M., and Morgan, A. J. 1993. Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin. J. Gen. Virol. 74: 501-507.
93. Roizman, B. 1991. Herpesviridae. pp. 103-110. In: Classification and Nomenclature of Viruses. Arch. Virol. [Supple. 2] (Francki, R. I. B., Fauquet, C. M., Knudson, D. L., and Brown, F. eds.), Springer-Verlag, Wien, New York.
94. Romero, C. H., Barrett, T., Evans, S. A., Kitching, R. P., Gershon, P. D., Bostock, C., and Black, D. N. 1993. Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 11: 737-742.
95. Romero, C. H., Barrett, T., Chamberlain, R. W., Kitching, R. P., Fleming, M., and Black, D. N. 1994. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: Protection of cattle against rinderpest and lumpy skin disease virus. Virology 204: 425-429.
96. Romero, C. H., Barrett, T., Kitching, R. P., Carn, V. M., and Black, D. N. 1994. Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Vet. Rec. 135: 152-154.
97. Romero, C. H., Barrett, T., Kitching, R. P., Bostock, C., and Black, D. N. 1995. Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus. Vaccine 13: 36-40.
98. Ross, L. J. N., Binns, M. M., Tyers, P., Pastorek, J., Zelnik, V., and Scott, S. 1993. Construction and properties of a turkey herpesvirus recombinant expressing the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J. Gen. Virol. 74: 371-377.
99. Shih, M. -F., Arsenakis, M., Tiollais, P., and Roizman, B. 1984. Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying α- and β- regulated gene chimeras. Proc. Natl. Acad. Sci. U.S.A. 81: 5867-5870.
100. Siebelink, K. H. J., Tijhaar, E., Huisman, R. C., Huisman, W., De Ronde, A., Darby, I. H., Francis, M. J., Rimmelzwaan, G. F., and Osterhaus, A. D. M. E. 1995. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J. Virol. 69: 3704-3711.
101. Slater, J. D., Gibson, J. S., and Field, H. J. 1993. Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals. J. Gen. Virol. 74: 819-828.
102. Smith, G. A., Young, P. L., Rodwell, B. J., Kelly, M. A., Storie, G. J., Farrah, C. A., and Mattick, J. S. 1994. Development and trial of a bovine herpesvirus 1-thymidine kinase deletion virus as a vaccine. Aust. Vet. J. 71: 65-70.
103. Sondermeijer, P. J. A., Claessens, J. A. J., Jenniskens, P. E., Mockett, A. P. A., Thijssen, R. A. J., Willemse, M. J., and Morgan, R. W. 1993. Avian herpesvirus as a live viral vector for the expression of heterologous antigens. Vaccine 11: 349-357.
104. Spatz, S. J. and Maes, R. K. 1993. Immunological characterization of the feline herpesvirus-1 glycoprotein B and analysis of its deduced amino acid sequence. Virology 197: 125-136.
105. Spatz, S. J., Rota, P. A., and Maes, R. K. 1994. Identification of the feline herpesvirus type 1 (FHV-1) genes encoding glycoproteins G, D, I and E: Expression of FHV-1 glycoprotein D in vaccinia and raccoon poxviruses. J. Gen. Virol. 75: 1235-1244.
106. Sussman, M. D., Maes, R. K., Kruger, J. M., Spatz, S. J., and Venta, P. J. 1995. A feline herpesvirus-1 recombinant with a deletion in the genes for glycoproteins gI and gE is effective as a vaccine for feline rhinotracheitis. Virology 214: 12-20.
107. Taylor, J., Weinberg, R., Kawaoka, Y., Webster, R. G., and Paoletti, E. 1988. Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 6: 504-508.
108. Taylor, J., Weinberg, R., Languet, B., Desmettre, P., and Paoletti, E. 1988. Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine 6 497-503.
109. Taylor, J., Ebdauer, C., Rey-Senelonge, A., Bouquet, J.-F., Norton, E., Goebel, S., Desmettre, P., and Paoletti, E. 1990. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J. Virol. 64: 1441-1450.
110. Taylor, J., Trimarchi, C., Weniberg, R., Languet. B., Guillemin, F., Desmettre, P., and Paoletti, E. 1991. Efficacy studies on a canarypox-rabies recombinant virus. Vaccine 9: 190-193.
111. Taylor, J., Weinberg, R., Tartaglia, J., Richardson, C., Alkhatib, G., Briedis, D., Appel, M., Norton, E., and Paoletti, E. 1992. Nonreplicating viral vectors as potential vaccines: Recombinant canary pox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 187: 321-328.
112. Tenser, R. B., Ressel, S. J., Fralish, F. A., and Jones, J. C. 1983. The role of pseudorabies virus thymidine kinase expression in trigeminal ganglion infection. J. Gen. Virol. 64: 1369-1373.
113. Tikoo, S. K., Campos, M., and Babiuk, L. A. 1995. Bovine herpesvirus 1: Biology, pathogenesis, and control. Adv. Virus. Res. 45: 191-223.
114. Torres, J. M.. Sáchez, C., Sun̄e, C., Smerdou, C., Prevec, L., Graham, F., and Enjuanes, L. 1995. Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein. Virology 213: 503-516.
115. Torres, J. M., Alonso, C., Ortega, A., Mittal, S., Graham, F., and Enjuanes, L. 1996. Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. J. Virol. 70: 3770-3780.
116. Van der Leek, M. L., Feller, J. A., Sorensen, G., Isaacson, W., Adams, C. L., Rorde, D. J., Pfeiffer, N., Tran, T., Moyer, R. W., and Gibbs, E. P. J. 1994. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63. Vet. Rec. 134: 13-18.
117. Van Oirschot, J. T., Gielkens,A. L. J., Moormann, R. J. M., and Berns, A. J. M. 1990. Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease. [Review]. Vet. Microbiol. 23: 85-101.
118. Van Zijl, M., Wensvoort, G., De Kluyver, E., Hulst, M., Van der Gulden, H., Gielkens, A., Berns, A., and Moormann, R. 1991. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J. Virol. 65: 2761-2765.
119. Verschoor, E. J., Willemse, M. J., Stam, J. G., Van Vliet, A. L. W., Pouwels, H., Chalmers, S. K., Horzinek, M. C., Sondermeijer, P. J. A., Hesselink, W., and De Ronde, A. 1996. Evaluation of subunit vaccines against feline immunodeficiency virus infection. Vaccine 14: 285-289.
120. Visser, N. and Lütticken, D. 1989. Experimences with a gI:/ TK: modified live pseudorabies virus vaccine: strain Begona. pp. 37-44. In: Vaccination and Control of Aujeszky's Disease (Van Oirschot, J. T. ed.), Kluwer Academic Publishers, Dordrecht.
121. Wade-Evans, A. M., Romero, C. H., Mellor, P., Takamatsu, H., Anderson, J., Thevasagayam, J., Fleming, M. J., Mertens, P. P. C., and Black, D. N. 1996. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 220: 227-231.
122. Wardley, R. C., Berlinski, P. J., Thomsen, D. R., Meyer, A. L., and Post, L. E. 1992. The use of feline herpesvirus and baculovirus as vaccine vectors for the gag and env genes of feline leukaemia virus. J. Gen. Virol. 73: 1811-1818.
123. Wild, F., Giraudon, P., Spehner, D., Drillien, R., and Lecoqo, J. P. 1990. Fowlpox virus recombinant encoding the measles virus fusion protein: Protection of mice against fatal measles encephalitis. Vaccine 8: 441-442.
124. Willemse, M. J., Chalmers, W. S. K., Cronenberg, A. M., Pfundt, R., Strijdeen, I. G. L., and Sondermeijer, P. J. A. 1994. The gene downstream of the gC homologue in feline herpesvirus type 1 is involved in the expression of virulence. J. Gen. Virol. 75: 3107-3116.
125. Willemse, M. J., Strijdveen, I. G. L., Van Schooneveld, S. H. B., Van den Berg, M. C., and Sondermeijer, P. J. A. 1995. Transcriptional analysis of the short segment of the feline herpesvirus type 1 genome and insertional mutagenesis of a unique reading frame. Virology 208: 704-711.
126. Willemse, M. J., Chalmers, W. S. K., and Sondermeijer, P. J. A. 1996. In vivo properties of a feline herpesvirus type 1 mutant carrying a lacZ insertion at the gI locus of the unique short segment. Vaccine 14: 1-5.
127. Willemse,M. J., Van Schooneveld, S. H. B., Chalmers, W. S. K., and Sondermeijer, P. J. A. 1996. Chapter 6: Vaccination against feline leukaemia using a new feline herpesvirus type 1 vector. pp. 75-86. In: Genetically Modified Feline Herpesvirus for Oronasal Vaccination of Cats (Willemse, M. J. ed.), Universiteit Utrecht., Utrecht.
128. Xiang, Z. Q., Yang, Y., Wilson, J. M , and Ertl, H. C. J. 1996. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219: 220-227.
129. Yilma, T. 1994. Genetically engineered vaccines for animal viral diseases. J. Am. Vet. Med. Assoc. 204: 1606-1615.
130. Yokoyama, N., Maeda, K., Kawaguchi, Y., Ono, M., Tohya, Y., and Mikami, T. 1995. Construction of the recombinant feline herpesvirus type 1 deleted thymidine kinase gene. J. Vet. Med. Sci. 57: 709-714.
131. Yokoyama, N., Maeda, K., Tohya, Y., Kawaguchi, Y., Shin, Y.-S., Ono, M., Ishiguro, S., Fujikawa, Y., and Mikami, T. 1996. Pathogenicity and vaccine efficacy of a thymidine kinase-deficient mutant of feline herpesvirus type 1 in cats. Arch. Virol. 141: 481-494.
132. Yokoyama, N., Maeda, K., Tohya, Y., Kawaguchi,Y., Fijita, K., and Mikami, T. 1996. Recombinant feline herpesvirus type 1 expressing immunogenic proteins inducible virus neutralizing antibody against feline calicivirus in cats. Vaccine 14: 1657-1663.
133. Yokoyama, N., Maeda, K., Fujita, K., Ishiguro, S., Sagawa, T., Mochizuki, M., Tohya, Y., and Mikami, T. 1996. Vaccine efficacy of recombinant feline herpesvirus type 1 expressing immunogenic proteins of feline calicivirus in cats. Arch. Virol. 141: 2339-2351.
134. Yoo, D., Graham, F. L., Prevec, L., Parker, M. D., Benko, M., Zamb, T., and Babiuk, L. A. 1992. Synthesis and processing of the haemagglutinin-esterase glycoprotein of bovine coronavirus encoded in the E3 region of adenovirus. J. Gen. Virol. 73: 2591-2600.
135. Young, P. L. and Smith, G. A. 1995. Genetically altered herpesviruses as vaccines. Vet. Microbiol. 46: 175-179.